[Technical Seminar] Business Development Strategies for Next-Generation Diagnostic Drugs and Companion Diagnostics
The future of personalized medicine created by multi-omics analysis and AI utilization, and the forefront of development and regulatory affairs.
This seminar will focus on the fields of "cancer" and "infectious diseases," explaining the essential technological elements, development schemes, processes for solving challenges, and future prospects necessary for the business development of related diagnostic drugs, taking into account the latest regulatory trends. It will cover the latest trends in in vitro diagnostic drugs, biomarkers and companion diagnostics, rapid diagnosis of infectious diseases, factors that differentiate success from failure, and the importance of overall design. *For more details, please check the related links or the seminar details in the catalog.*
Inquire About This Product
basic information
<Event Information> Format: In-person attendance (no online streaming) Location: Japan IR Headquarters Seminar Room (Akihabara, Tokyo) Date and Time: November 27, 2026 (Friday) 13:00 - 17:00 Participation Fee: 49,500 yen per person (tax included) Instructor: Hiroshi Tamura
Price range
Delivery Time
Applications/Examples of results
<Seminar Program (Tentative)> Chapter 1: Latest Trends and Business Environment of In Vitro Diagnostic Products Chapter 2: Frontiers of Biomarkers and Companion Diagnostics (CDx) Chapter 3: Contribution to Rapid Diagnosis and Early Treatment of Infectious Diseases Chapter 4: Factors that Separate Success and Failure and the Importance of Overall Design Chapter 5: Q&A and Discussion
catalog（1）
Download All Catalogs
Company information
We support Japan's "monozukuri" (manufacturing) with reliable services ranging from patent research and other intellectual property business solutions to technical translation services and intellectual property/engineer education. We offer high-quality services backed by over 40 years of experience at reasonable prices.
